BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19443030)

  • 1. A leukemic plasmacytoid dendritic cell line, PMDC05, with the ability to secrete IFN-alpha by stimulation via Toll-like receptors and present antigens to naïve T cells.
    Narita M; Watanabe N; Yamahira A; Hashimoto S; Tochiki N; Saitoh A; Kaji M; Nakamura T; Furukawa T; Toba K; Fuse I; Aizawa Y; Takahashi M
    Leuk Res; 2009 Sep; 33(9):1224-32. PubMed ID: 19443030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of antigen-specific cytotoxic T lymphocytes using a leukemic plasmacytoid dendritic cell line as antigen presenting cells.
    Yamahira A; Narita M; Nakamura T; Watanabe N; Kaji M; Taniguchi T; Hashimoto S; Furukawa T; Toba K; Aizawa Y; Kuzushima K; Takahashi M
    Leuk Res; 2011 Jun; 35(6):793-9. PubMed ID: 21216464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
    Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
    J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
    Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
    J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmacytoid dendritic cell leukemia with potent antigen-presenting ability.
    Narita M; Kuroha T; Watanabe N; Hashimoto S; Tsuchiyama J; Tochiki N; Saitoh A; Satoh N; Furukawa T; Toba K; Fuse I; Aizawa Y; Takahashi M
    Acta Haematol; 2008; 120(2):91-9. PubMed ID: 18948686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation of dendritic cells from plasmacytoid to myeloid in a leukemic plasmacytoid dendritic cell line (PMDC05).
    Watanabe N; Narita M; Yamahira A; Nakamura T; Tochiki N; Saitoh A; Kaji M; Hashimoto S; Furukawa T; Toba K; Fuse I; Aizawa Y; Takahashi M
    Leuk Res; 2010 Nov; 34(11):1517-24. PubMed ID: 20338639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR2 promotes Th2/Th17 responses via TLR4 and TLR7/8 by abrogating the type I IFN amplification loop.
    Wenink MH; Santegoets KC; Broen JC; van Bon L; Abdollahi-Roodsaz S; Popa C; Huijbens R; Remijn T; Lubberts E; van Riel PL; van den Berg WB; Radstake TR
    J Immunol; 2009 Dec; 183(11):6960-70. PubMed ID: 19915052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of antigen presenting ability in the leukemic plasmacytoid dendritic cell line (PMDC05) by lentiviral vector-mediated transduction of CD80 gene.
    Yamahira A; Narita M; Ishii K; Jayathilake RM; Iwabuchi M; Satoh N; Uchiyama T; Taniguchi T; Hashimoto S; Kasahara N; Faure E; Bogan B; Takizawa J; Sone H; Takahashi M
    Leuk Res; 2012 Dec; 36(12):1541-6. PubMed ID: 23040531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7.
    Hornung V; Guenthner-Biller M; Bourquin C; Ablasser A; Schlee M; Uematsu S; Noronha A; Manoharan M; Akira S; de Fougerolles A; Endres S; Hartmann G
    Nat Med; 2005 Mar; 11(3):263-70. PubMed ID: 15723075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells.
    Martinelli E; Cicala C; Van Ryk D; Goode DJ; Macleod K; Arthos J; Fauci AS
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3396-401. PubMed ID: 17360657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.
    Garnache-Ottou F; Feuillard J; Ferrand C; Biichle S; Trimoreau F; Seilles E; Salaun V; Garand R; Lepelley P; Maynadié M; Kuhlein E; Deconinck E; Daliphard S; Chaperot L; Beseggio L; Foisseaud V; Macintyre E; Bene MC; Saas P; Jacob MC;
    Br J Haematol; 2009 Jun; 145(5):624-36. PubMed ID: 19388928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional dichotomy of plasmacytoid dendritic cells: antigen-specific activation of T cells versus production of type I interferon.
    Jaehn PS; Zaenker KS; Schmitz J; Dzionek A
    Eur J Immunol; 2008 Jul; 38(7):1822-32. PubMed ID: 18581320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signalling pathways leading to IFN-alpha production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications.
    Guiducci C; Coffman RL; Barrat FJ
    J Intern Med; 2009 Jan; 265(1):43-57. PubMed ID: 19093959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of antigen-specific cytotoxic T lymphocytes by fusion cells generated from allogeneic plasmacytoid dendritic and tumor cells.
    Koido S; Homma S; Kan S; Takakura K; Namiki Y; Kobayashi H; Ito Z; Uchiyama K; Kajihara M; Arihiro S; Arakawa H; Okamoto M; Ohkusa T; Gong J; Tajiri H
    Int J Oncol; 2014 Jul; 45(1):470-8. PubMed ID: 24819411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic of RelA activation controls magnitude of TLR-mediated IL-12p40 induction.
    Bode KA; Schmitz F; Vargas L; Heeg K; Dalpke AH
    J Immunol; 2009 Feb; 182(4):2176-84. PubMed ID: 19201871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human B cell responses to TLR ligands are differentially modulated by myeloid and plasmacytoid dendritic cells.
    Douagi I; Gujer C; Sundling C; Adams WC; Smed-Sörensen A; Seder RA; Karlsson Hedestam GB; Loré K
    J Immunol; 2009 Feb; 182(4):1991-2001. PubMed ID: 19201852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of six-color flow cytometry for the assessment of dendritic cell responses in whole blood assays.
    Della Bella S; Giannelli S; Taddeo A; Presicce P; Villa ML
    J Immunol Methods; 2008 Dec; 339(2):153-64. PubMed ID: 18835394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon regulatory factor 7-mediated responses are defective in cord blood plasmacytoid dendritic cells.
    Danis B; George TC; Goriely S; Dutta B; Renneson J; Gatto L; Fitzgerald-Bocarsly P; Marchant A; Goldman M; Willems F; De Wit D
    Eur J Immunol; 2008 Feb; 38(2):507-17. PubMed ID: 18200500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the leukemia plasmacytoid dendritic cell line PMDC05 by Toho-1, a novel IDO inhibitor.
    Yamahira A; Narita M; Iwabuchi M; Uchiyama T; Iwaya S; Ohiwa R; Nishizawa Y; Suzuki T; Yokoyama Y; Hashimoto S; Takizawa J; Sone H; Takahashi M
    Anticancer Res; 2014 Aug; 34(8):4021-8. PubMed ID: 25075025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting Edge: TLR-Dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells.
    Kumagai Y; Kumar H; Koyama S; Kawai T; Takeuchi O; Akira S
    J Immunol; 2009 Apr; 182(7):3960-4. PubMed ID: 19299691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.